Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / THTX - Evelo Trial Progress And Other News: The Good Bad And Ugly Of Biopharma


THTX - Evelo Trial Progress And Other News: The Good Bad And Ugly Of Biopharma

Evelo Bio Moves Ahead with EDP1815 Mid Stage Trial

Evelo Biosciences Inc. (EVLO) announced that its lead drug candidate EDP1815 will now be a part of TACTIC-E clinical trial. The trial is designed to assess the safety and efficacy of certain experimental therapies in the preventing and treating various complications related to COVID-19.

TACTIC-E is a Phase 2/3 randomized trial and will involve up to 469 patients in each arm. The participants will be the patients suffering from COVID-19 who have identified risk factors for developing severe complications. These will be patients who

Read more ...

Stock Information

Company Name: Theratechnologies Inc.
Stock Symbol: THTX
Market: NASDAQ
Website: theratech.com

Menu

THTX THTX Quote THTX Short THTX News THTX Articles THTX Message Board
Get THTX Alerts

News, Short Squeeze, Breakout and More Instantly...